Published in Gene Therapy Weekly, September 29th, 2005
Currently, AML patients with either the 8;21 translocation or the inversion 16 abnormalities receive the same therapy. They...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.